A bibliometric analysis of research progress on pharmacovigilance and cancer from 2002 to 2021

Abstract

The complexity of cancer itself and treatment makes pharmacovigilance critical in oncology. Despite rapid progress on pharmacovigilance and cancer research in the past two decades, there has been no bibliometric analysis in this field. Therefore, based on the Web of Science database, we used CiteSpace, VOS-viewer and R-bibliometrix to analyze and visualize publications, and described the development trend and research hot spots in this field. 502 publications were included. The development of pharmacovigilance and cancer research has continued to grow. The USA has the largest number of publications and citations, followed by France and UK. Vanderbilt University and Sorbonne University are the institutions that contribute the most papers, and 5 of the top 10 high-yield institutions are from France. Salem JE and Lebrun-Vignes B of Sorbonne University have published the most papers, and they have a strong cooperative relationship. Salem JE has the highest H index. Drug Safety has the largest number of publications in the field of pharmacovigilance and cancer, with a high impact factor (IF). In recent years, immune checkpoint inhibitors (ICIs) have been identified as a hot topic and will continue to be maintained. This paper can help researchers get familiar with the current situation and trend of pharmacovigilance and cancer research, and provide valuable reference for the selection of future research directions.

Visualization of the relationship between fungi and cancer from the perspective of bibliometric analysis

“…The achievement of a thorough and comprehensive comprehension of the intricate mechanisms that govern the interaction between fungi and cancer is an essential prerequisite for developing innovative therapeutic approaches to combat this multifarious and enigmatic disease. In this regard, bibliometric analysis emerges as a quantitative method that meticulously examines scientific publications and citation patterns, furnishing valuable insights into the trajectory and impact of research within a particular domain [ 44 , [46] , [47] , [48] , [49] , [50] , [51] , [102] , [103] , [104] , [105] ]. Through the rigorous scrutiny of publication output and citation trends, researchers can effectively evaluate the current state of research pertaining to the interplay between fungi and cancer, identify significant gaps in knowledge, and discern domains that require further exploration and analysis.…”

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

“…Therefore, a focus on DA seems timely and Drug Safety, the official journal of the International Society of Pharmacovigilance (ISoP), is one of the journals of choice for researchers in the field. Of note, DAs have also attracted the interest of a number of 'clinical' journals, especially in the field of oncology in immune checkpoint inhibitors [6][7][8].…”